India, Aug. 3 -- AstraZeneca PLC (AZN) shares fell sharply following reports that the drugmaker has held discussions with Bristol Myers Squibb over a potential merger that could create one of the world's largest pharmaceutical companies.
The stock is currently trading at $155.27, down $14.37 or 8.47%, on the Nasdaq. It opened at $157.16 after closing the previous session at $169.64. The stock has traded between $145.80 and $212.71 over the past 52 weeks.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....